The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.
A framework for analyzing single-cell genomics data, in which geometrical properties are harnessed to obtain insights on cellular diversity, including precise clustering, clear visualizations, and ...